BLCR ETF review: active fundamental+quant strategy, 2025 return beat QQQ/IVV, but higher volatility and mixed risk-adjusted ...

Targeted tech exposure or broader diversification? Unpack how portfolio makeup and sector focus set these two growth ETFs apart.

A smart beta exchange traded fund, the First Trust NASDAQ-100 Select Equal Weight ETF (QQEW) debuted on 04/19/2006, and offers broad exposure to the Style Box - Large Cap Growth category of the market ...

Low-volatility ETFs hold the lowest-volatility stocks within a selection universe. For instance, an S&P 500 low-vol ETF would ...

To find out if you’re on track to reach your financial goals, review your current portfolio balance, combined with your ...

Build a stable income portfolio with top AAA CLO bond ETFs (PAAA, CLOB, UYLD) for high yield, low drawdown, and capital ...

Alameda staff, begins private beta of a unified prediction platform amid growing scrutiny of the market and insider trading ...

Learn how the portable alpha strategy can enhance your portfolio returns by leveraging low-correlation assets for alpha while ...

U.S. commercial launch in thalassemia underway following December 2025 FDA approvalPre-sNDA meeting with FDA for mitapivat in sickle cell disease anticipated in first quarter of 2026, with planned U.S ...

Merve Ceylan is a dietitian and health writer with four years of experience writing for companies in the nutrition and health industry. Curcumin in turmeric can decrease body mass index (BMI), body ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

The success of GLP-1 medications has made drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) seem like a magic bullet for weight loss. But using these drugs doesn't mean you ...